BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29

• Genetown

  SeraCare Life Sciences, Inc. Announces Expansion of Cellular Product Line

  April 27, 2011

   · 

  1 min read
• Business

  Illumina, Inc. Reports Financial Results for First Quarter 2011

  April 27, 2011

   · 

  1 min read
• Inhibitex, Inc. to Present at Two Upcoming Investor Conferences

  April 27, 2011

   · 

  1 min read
• Provectus Pharmaceuticals Inc. Receives Orphan Drug Designation from FDA for the Treatment of Liver Cancer

  April 27, 2011

   · 

  4 min read
• Business

  Dyax Corp. and FivePrime Therapeutics, Inc. Enter Into Research Agreement for Discovery of Therapeutic Antibodies

  April 27, 2011

   · 

  1 min read
• Drug Development

  Vical Incorporated Announces Encouraging H1N1 Pandemic Influenza Vaccine Phase 1 Results

  April 27, 2011

   · 

  1 min read
• Drug Development

  BioAlliance Pharma Accelerates its European Clinical Development of Clonidine Lauriad(TM)

  April 27, 2011

   · 

  1 min read
• Pharm Country

  BioNJ Hosts Second Annual BioPartnering International Conference on May 23-24 in Princeton

  April 27, 2011

   · 

  1 min read
• Business

  EXACT Sciences Corporation to Host First-Quarter 2011 Results Conference Call

  April 27, 2011

   · 

  1 min read
• Drug Development

  BioInvent and ThromboGenics NV Have Dosed the First Patient in Phase IIb Trial of TB-402 (Anti-Factor VIII) for Venous Thromboembolism (VTE) Prophylaxis

  April 27, 2011

   · 

  7 min read